Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
J Med Assoc Thai. 2009.
PMID: 20128070
Search Page
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
| Year | Number of Results |
|---|---|
| 1999 | 1 |
| 2000 | 6 |
| 2001 | 9 |
| 2002 | 6 |
| 2003 | 15 |
| 2004 | 15 |
| 2005 | 10 |
| 2006 | 17 |
| 2007 | 21 |
| 2008 | 14 |
| 2009 | 11 |
| 2010 | 12 |
| 2011 | 7 |
| 2012 | 7 |
| 2013 | 9 |
| 2014 | 6 |
| 2015 | 7 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 5 |
| 2019 | 4 |
| 2020 | 5 |
| 2021 | 3 |
| 2022 | 2 |
| 2023 | 1 |
| 2024 | 1 |
Search Results
191 results
Results by year
Citations
2
articles
found by citation matching
Risks and benefits of COX-2 inhibitors vs non-selective NSAIDs: does their cardiovascular risk exceed their gastrointestinal benefit? A retrospective cohort study.
Rheumatology (Oxford). 2007.
PMID: 17255138
Search results
Page 1
Non-steroidal anti-inflammatory drugs (NSAIDs), pain and aging: Adjusting prescription to patient features.
Biomed Pharmacother. 2022 Jun;150:112958. doi: 10.1016/j.biopha.2022.112958. Epub 2022 Apr 19.
Biomed Pharmacother. 2022.
PMID: 35453005
Free article.
Review.
Selective COX-2 inhibitors are associated with higher cardiovascular risk, while non-selective COX inhibitors are associated with higher gastrointestinal risk. ...Polymedicated patients, elderly patients, and patients with chronic alcohol abuse …
Selective COX-2 inhibitors are associated with higher cardiovascular risk, while non-selective COX inhibitors are assoc …
Safety of Oral Non-Selective Non-Steroidal Anti-Inflammatory Drugs in Osteoarthritis: What Does the Literature Say?
Drugs Aging. 2019 Apr;36(Suppl 1):15-24. doi: 10.1007/s40266-019-00660-1.
Drugs Aging. 2019.
PMID: 31073921
Free PMC article.
Review.
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely recommended and prescribed to treat pain in osteoarthritis. ...Osteoarthritis is associated with excess mortality, which may be explained by reduced levels of physical activity owing to l …
Non-steroidal anti-inflammatory drugs (NSAIDs) are widely recommended and prescribed to treat pain in ost …
Nonsteroidal anti-inflammatory drugs for dysmenorrhoea.
Cochrane Database Syst Rev. 2015 Jul 30;2015(7):CD001751. doi: 10.1002/14651858.CD001751.pub3.
Cochrane Database Syst Rev. 2015.
PMID: 26224322
Free PMC article.
Review.
The COX enzyme exists in two forms, COX-1 and COX-2. Traditional NSAIDs are considered 'non-selective' because they inhibit both COX-1 and COX-2 enzymes. ...MAIN RESULTS: We included 80 randomised controlled trials (5820 women). They compared 20 different …
The COX enzyme exists in two forms, COX-1 and COX-2. Traditional NSAIDs are considered 'non-selective' because they inh …
Guidance on the management of pain in older people.
Age Ageing. 2013 Mar;42 Suppl 1:i1-57. doi: 10.1093/ageing/afs200.
Age Ageing. 2013.
PMID: 23420266
Review.
It is, however, important that the maximum daily dose (4 g/24 h) is not exceeded. Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) should be used with caution in older people after other safer treatments have not provid …
It is, however, important that the maximum daily dose (4 g/24 h) is not exceeded. Non-selective non-steroidal …
Non-selective non-steroidal anti-inflammatory drugs (NSAIDs) and cardiovascular risk.
Acta Biomed. 2013 Jun 1;84(1):5-11.
Acta Biomed. 2013.
PMID: 24189757
Review.
NSAIDs are largely used for the treatment of a huge variety of clinical conditions in order to relieve symptoms related to inflammation.The use of NSAIDs is associated with a potential increased risk of gastrointestinal and cardiovascular complications …
NSAIDs are largely used for the treatment of a huge variety of clinical conditions in order to relieve symptoms related to inflammati …
[Non-steroidal Anti-inflammatory Drugs and Cardiovascular Risk].
Praxis (Bern 1994). 2023 Jan;112(1):16-21. doi: 10.1024/1661-8157/a003948.
Praxis (Bern 1994). 2023.
PMID: 36597690
Free article.
German.
Non-steroidal Anti-inflammatory Drugs and Cardiovascular Risk Abstract. Non-steroidal anti-inflammatory drugs (NSAIDs) are amongst the most frequently used drugs worldwide, although medically controlled prescri …
Non-steroidal Anti-inflammatory Drugs and Cardiovascular Risk Abstract. Non-steroidal an …
Non-steroidal anti-inflammatory drug (NSAID) therapy in patients with hypertension, cardiovascular, renal or gastrointestinal comorbidities: joint APAGE/APLAR/APSDE/APSH/APSN/PoA recommendations.
Gut. 2020 Apr;69(4):617-629. doi: 10.1136/gutjnl-2019-319300. Epub 2020 Jan 14.
Gut. 2020.
PMID: 31937550
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed medications, but they are associated with a number of serious adverse effects, including hypertension, cardiovascular disease, kidney injury and G …
BACKGROUND: Non-steroidal anti-inflammatory drugs (NSAIDs) are one of the most commonly prescribed medica …
Gastrointestinal and cardiovascular risk of non-selective NSAIDs and COX-2 inhibitors in elderly patients with knee osteoarthritis.
J Med Assoc Thai. 2009 Dec;92 Suppl 6:S19-26.
J Med Assoc Thai. 2009.
PMID: 20128070
OBJECTIVE: To evaluate the incidence and risk profiles for gastrointestinal (GI) events and cardiovascular (CV) events in elderly patients (aged > or =60 years) with knee osteoarthritis using tNSAIDs (traditional non-steroidal anti-inflamm …
OBJECTIVE: To evaluate the incidence and risk profiles for gastrointestinal (GI) events and cardiovascular (CV) events in elde …
Cardiovascular and gastrointestinal toxicity of selective cyclo-oxygenase-2 inhibitors in man.
J Physiol Pharmacol. 2008 Aug;59 Suppl 2:117-33.
J Physiol Pharmacol. 2008.
PMID: 18812633
Review.
It is well established that the use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs) increase the vulnerability of the gastrointestinal (GI) mucosa for the development of peptic lesions and serious ulcer complications. ...Many subsequent st …
It is well established that the use of traditional nonsteroidal anti-inflammatory drugs (NSAIDs) increase the vulnerabi …
Gastrointestinal effects of NSAIDs and coxibs.
J Pain Symptom Manage. 2003 Feb;25(2 Suppl):S32-40. doi: 10.1016/s0885-3924(02)00629-2.
J Pain Symptom Manage. 2003.
PMID: 12604155
Free article.
Review.
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used drugs in the world, but their use is limited because of their propensity to cause gastrointestinal (GI) injury. ...The COX-2 specific inhibitors (coxibs) were developed with …
Nonsteroidal anti-inflammatory drugs (NSAIDs) are among the most commonly used drugs in the world, but their use is lim …
Cite